News

Success for some is the measure of wealth they have accumulated, while for some it is the respect they have earned. The word holds different meaning for different people. For Emmanuel Vincent, the Co-founder and CEO of Aenitis Technologies, it is the measure of how many lives he has saved or improved. Although, together we can move mountains but the strong determination and perseverance of one person can also make a difference in this world and that is what this 41-year young healthcare leader is set to do. Emmanuel is driven by activities involving social impact and is value creation oriented.

“This funding will help to accelerate the roll-out of acoustic blood cell sorting technology to industrial scale”‍ Aenitis Technologies, which develops new medical equipment based on acoustic manipulation of biological particles, today announced that it has received €4 million in funding, following its application to the highly-selective SME Instrument Phase 2 European programme, in the “Healthcare Biotechnology” category. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171130005528/en/ SME Instrument Phase 2 is part of Horizon 2020, a programme managed by the European Commission and dedicated to innovation and research. It is part of the Industrial